Brooklyn biotech files 40-claim patent application covering a new active-ingredient combination for over-the-counter headache ...

Indian industrial biotech company Praj Industries has launched an Advanced Precision Fermentation Lab at its Praj Matrix R&D ...

Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...

This collaboration combines Geltor’s category-defining expertise in biodesigned peptides and proteins with TOSLA’s leadership ...

Last month, Tony Lyons, the ally of the health secretary who runs the MAHA PAC, said he’d raise $100 million to support ...

Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech") announces today its fourth quarter and full year 2025 financial results.

Congressional lawmakers introduced a raft of proposals this week, including bills to balance the power needs of data centers ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Regeneron reached an agreement with the U.S. government to link current and future drug prices to those in other developed ...

Citius Pharmaceuticals CTXR shares tumbled on Friday after the company announced a registered direct offering, a financing ...

Epitopea has confirmed the Institute of Cancer Research Professor in Women’s Cancers, Susana Banerjee, as chief investigator ...

Oncotelic Therapeutics, Inc. ('Oncotelic” or the 'Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today provided a corporate update on its ...